SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $942,000 | – | 8,525 | +141983.3% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 6 | -99.8% | 0.00% | -100.0% |
Q1 2021 | $204,000 | -71.4% | 2,732 | -34.8% | 0.00% | -50.0% |
Q4 2020 | $714,000 | -8.2% | 4,188 | -24.4% | 0.00% | 0.0% |
Q3 2020 | $778,000 | +21.4% | 5,540 | -15.4% | 0.00% | -33.3% |
Q1 2020 | $641,000 | -33.6% | 6,549 | -12.5% | 0.00% | 0.0% |
Q4 2019 | $966,000 | +68.6% | 7,488 | -1.6% | 0.00% | +50.0% |
Q3 2019 | $573,000 | -53.9% | 7,611 | -6.9% | 0.00% | -50.0% |
Q2 2019 | $1,243,000 | +14.7% | 8,178 | -10.1% | 0.00% | 0.0% |
Q1 2019 | $1,084,000 | +14.0% | 9,097 | +4.4% | 0.00% | 0.0% |
Q4 2018 | $951,000 | -36.6% | 8,710 | -6.3% | 0.00% | -33.3% |
Q3 2018 | $1,501,000 | +24.2% | 9,295 | +1.6% | 0.01% | +20.0% |
Q2 2018 | $1,209,000 | +75.7% | 9,150 | -1.4% | 0.01% | +66.7% |
Q1 2018 | $688,000 | +25.1% | 9,280 | -6.1% | 0.00% | +50.0% |
Q4 2017 | $550,000 | +25.0% | 9,880 | +2.0% | 0.00% | 0.0% |
Q3 2017 | $440,000 | – | 9,690 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |